The Influence of Pharmacological Preconditioning with Sevoflurane on Incidence of Early Allograft Dysfunction in Liver Transplant Recipients

Table 2

Recipient characteristics.

	Sevoflurane group	Control group	Mann-Whitney, 𝑃 value
Recipient age, y	44 (28–55)	49 (34–55)	0,865*
MELD score	20 (15–27)	17 (14–26)	0,340*
Baseline AST, IU/L	86 (32–154)	90 (34–171)	0,955*
Baseline ALT, IU/L	62 (17–126)	63 (20–220)	0,985*
Beta-blocker therapy, y/n	17/13	15/15	0,796**

Data are as median (interquartile range).
*Mann-Whitney test, **Fisher’s exact test, two tailed.